checkAd

     409  0 Kommentare Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community - Seite 3

    Corporate Contact:                                      
    Kevin R. Lind
    Arena Pharmaceuticals, Inc.
    Executive Vice President and
    Chief Financial Officer                                   
    klind@arenapharm.com 
    858.210.3636

    Media Contact:
    Matt Middleman, MD
    LifeSci Public Relations
    matt.middleman@lifescipublicrelations.com 
    646.627.8384

    Arena Pharmaceuticals Logo (PRNewsFoto/Arena Pharmaceuticals, Inc.)

    Logo - https://mma.prnewswire.com/media/436843/Arena_Pharmaceuticals_Logo.jpg

    Seite 3 von 3




    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community - Seite 3 - New open-label extension data from the Phase 2 OASIS trial for etrasimod in ulcerative colitis - Arena sponsored breakfast symposium: Will oral therapies change the IBD treatment landscape? - Visit Arena in the exhibit hall at booth #78 SAN …